Antipsychotic-Related Fatal Poisoning, England and Wales, 1993-2019

被引:5
作者
Handley, Simon Alfred [1 ,2 ]
Every-Palmer, Susanna [3 ]
Flanagan, Robert James [4 ,5 ]
机构
[1] Royal Hobart Hosp, Dept Pathol, Hobart, Tas, Australia
[2] Univ Tasmania, Menzies Res Inst, Sch Med, Hobart, Tas, Australia
[3] Univ Otago, Dept Psychol Med, Wellington, New Zealand
[4] Kings Coll Hosp London, Dept Precis Med, Networked Serv, London, England
[5] Kings Coll Hosp NHS Fdn Trust, Networked Serv, Precis Med, 3rd Flr,Bessemer Wing,Denmark Hill, London SE5 9RS, England
关键词
antipsychotics; death; poisoning; suicide; clozapine; toxicity;
D O I
10.1097/JCP.0000000000001479
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Supplemental digital content is available in the text. BackgroundDeaths from antipsychotic (AP) poisoning have increased in England and Wales despite restriction of the use of thioridazine in 2000.MethodsWe analyzed data from the Office for National Statistics drug-related death database, England and Wales, 1993-2019, to investigate fatal AP poisoning.ResultsThere were 2286 deaths (62% male patients). Annual numbers of intentional AP-related fatal poisonings (suicides) were relatively stable (1993, 35; 2019, 44; median, 44; range, 30-60). Intentional overdose deaths involving clozapine (96 male, 25 female) increased from 1 in 1994 to 5 in 2003 and have since remained relatively constant (median, 6; range, 3-10 per annum). Unintentional second-generation AP-related fatal poisonings have increased steadily since 1998, featuring in 828 (74%) of all unintentional, AP-related fatal poisonings in the period studied (2019, 89%). There were 181 unintentional clozapine-related deaths, (107 [59%] alone without other drugs +/- alcohol) as compared with 291 quetiapine-related deaths (86 [30%] alone without other drugs +/- alcohol) and 314 unintentional olanzapine-related deaths (77 [25%] alone without other drugs +/- alcohol). Some 75% of all unintentional clozapine- and olanzapine-related deaths were of male patients (78% and 73%, respectively) as compared with 58% of unintentional quetiapine-related fatal poisonings. Clozapine now features prominently in intentional and in unintentional AP-related fatal poisoning in England and Wales. Deaths of male patients predominate in both categories. There were also 77 and 86 deaths attributed to unintentional poisoning with olanzapine and with quetiapine, respectively, in the absence of other drugs.ConclusionsMore effort is needed to prevent unintentional deaths not only from clozapine but also from olanzapine and quetiapine.
引用
收藏
页码:650 / 657
页数:8
相关论文
共 29 条
[1]   A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes [J].
Barbosa, L ;
Berk, M ;
Vorster, M .
JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (04) :403-407
[2]   A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder [J].
Bowden, CL ;
Calabrese, JR ;
Sachs, G ;
Yatham, LN ;
Asghar, SA ;
Hompland, M ;
Montgomery, P ;
Earl, N ;
Smoot, TM ;
DeVeaugh-Geiss, J .
ARCHIVES OF GENERAL PSYCHIATRY, 2003, 60 (04) :392-400
[3]   A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder [J].
Calabrese, JR ;
Bowden, CL ;
Sachs, G ;
Yatham, LN ;
Behnke, K ;
Mehtonen, OP ;
Montgomery, P ;
Ascher, J ;
Paska, W ;
Earl, N ;
DeVeaugh-Geiss, J .
JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (09) :1013-1024
[4]   A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression [J].
Calabrese, JR ;
Bowden, CL ;
Sachs, GS ;
Ascher, JA ;
Monaghan, E ;
Rudd, GD .
JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 (02) :79-+
[5]   Incidence, prevalence and clinical correlates of antidepressant-emergent mania in bipolar depression: a systematic review and meta-analysis [J].
Fornaro, Michele ;
Anastasia, Annalisa ;
Novello, Stefano ;
Fusco, Andrea ;
Solmi, Marco ;
Monaco, Francesco ;
Veronese, Nicola ;
De Berardis, Domenico ;
de Bartolomeis, Andrea .
BIPOLAR DISORDERS, 2018, 20 (03) :195-227
[6]   Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review [J].
Fornaro, Michele ;
De Berardis, Domenico ;
Koshy, Ann Sarah ;
Perna, Giampaolo ;
Valchera, Alessandro ;
Vancampfort, Davy ;
Stubbs, Brendon .
NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 :719-735
[7]   Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials [J].
Geddes, John R. ;
Calabrese, Joseph R. ;
Goodwin, Guy M. .
BRITISH JOURNAL OF PSYCHIATRY, 2009, 194 (01) :4-9
[8]   Lamotrigine augmentation in treatment-resistant unipolar depression: A comprehensive meta-analysis of efficacy and safety [J].
Goh, Kah Kheng ;
Chen, Chun-Hsin ;
Chiu, Yi-Hang ;
Lu, Mong-Liang .
JOURNAL OF PSYCHOPHARMACOLOGY, 2019, 33 (06) :700-713
[9]  
Ivkovic M, 2009, PSYCHIAT DANUB, V21, P187
[10]  
Kagawa S., 2010, Clin Neuropsychopharmacol Ther, V1, P35